Nourish Raises $100M Series C as Investors Eye Post-GLP-1 Plays

Nourish, a telehealth platform that pairs patients with registered dietitians, comes as more people take weight-loss drugs but struggle with what comes next

Nourish, a New York-based virtual nutrition clinic, has closed a $100 million Series C led by Menlo Ventures, bringing total funding to $215 million in just over four years.

The round lands roughly 13 months after the company’s $70 million Series B and will fuel Nourish’s clinical network, support its investment in AI agents and partnerships with health plans and employers.

Thrive Capital, Index Ventures, J.P. Morgan Growth Equity Partners, Maverick Ventures, Y Combinator, BoxGroup, Atomico, Daybreak and Operator Partners joined the round. J.P. Sanday, a partner at Menlo, will join Nourish’s board.

Nourish pairs patients with registered dietitians (RDs), who provide care plans that include lab testing, GLP-1s for those who qualify, medication management and more, all in coordination with a patient’s existing providers in a telehealth format. A mobile app supports patients along the way with direct messaging their RD, meal tracking and recipes.

Prospective patients can check their coverage through a calculator on Nourish’s website, which verifies whether the company accepts their insurance. Nourish says 94% of its patients pay nothing out of pocket. The company also offers private-pay sessions at $145 each for patients without coverage.

Though Nourish says GLP-1s have driven demand, there’s a retention problem that has insurers and employers paying attention. Fewer than half of patients remain on the weight loss medications at six months, the platform says, and most who stop regain the weight without nutrition and behavior support to back them up.

“Chronic disease is the largest cost driver in U.S. healthcare, and the system still isn’t built to treat it,” said Nourish CEO and co-founder Aidan Dewar. “Too often, patients get expensive, reactive, fragmented care that doesn’t actually make them healthier. We’ve built the care model and technology to change that – driving the behavior and lifestyle change that deliver real clinical outcomes at a low cost and great patient experience.”

“The demand from patients, providers, health plans, employers and health systems has never been clearer, and this round positions us to meet it at scale,” he added.

The platform reports high success rates, with Nourish patients experiencing 8% weight loss, a 1.3-point A1C reduction, a 31-point LDL cholesterol reduction and a 23-point systolic blood pressure reduction, which it says result in over $2,000 per patient in annual cost savings for health plans.

While GLP-1 users’ appetites may be slightly blunted, the same can’t be said for investors when it comes to telehealth platforms centered on metabolic and nutrition care.

In addition to Nourish, Fay, a digital nutritional therapy platform that also connects consumers with registered dietitians, raised $50 million at a $500 million valuation late last year. Telehealth platform Berry Street, which raised $50 million of its own in 2025, recently joined Amazon’s Health Benefits Connector, giving its network of 1,500 registered dietitians a path to Amazon customers searching for covered care.